Aptorum Group Limited (APM) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Aptorum Group Limited (APM) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $6.5M, listed on NASDAQ, employing roughly 1 people, carrying a beta of 0.09 to the broader market. Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. Led by Chung Yuen Huen, public since 2018-12-18.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for APM as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →